Company Valuation: Clinitech Laboratory Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2025
Market Cap 1 91.84
Change -
Enterprise Value (EV) 1 61.1
Change -
P/E 21.2x
PBR 1.04x
PEG -1.1x
Capitalization / Revenue 1.12x
EV / Revenue 0.74x
EV / EBITDA 7.34x
EV / EBIT 16x
EV / FCF -
FCF Yield -
Dividend per Share 2 -
Rate of return -
EPS 2 1.896
Distribution rate -
Net sales 1 82.35
EBITDA 1 8.319
EBIT 1 3.821
Net income 1 3.947
Net Debt 1 -30.75
Reference price 2 40.24
Nbr of stocks (in thousands) 2,282
Announcement Date 26/8/25
1INR in Million2INR
Estimates

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 1.04M
-157.47x13.04x-178.47x-.--% 37.51B
18.86x1.82x10.53x1.07% 22.26B
16.39x1.29x7.35x5.31% 6.97B
311.49x - - - 4.78B
55.68x9.85x34.57x0.83% 2.99B
-23.29x - - - 2.07B
-31.79x - - -.--% 1.85B
29.63x1.05x8.77x0.85% 1.7B
12.27x1.29x5.05x6.16% 1.64B
Average 25.75x 4.72x -18.70x 2.03% 8.18B
Weighted average by Cap. -45.92x 7.83x -85.97x 1%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. 544220 Stock
  4. Valuation Clinitech Laboratory Limited